Literature DB >> 25328953

Osteosarcoma survivors' risk of second cancer.

Sanjeet Bagcchi.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25328953     DOI: 10.1016/s1470-2045(14)70394-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

1.  The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma.

Authors:  Ling Wang; Fu-Biao Kang; Nan Sun; Juan Wang; Wei Chen; Dong Li; Bao-En Shan
Journal:  Tumour Biol       Date:  2016-09-20

2.  CircRNA CDR1as/miR-7 signals promote tumor growth of osteosarcoma with a potential therapeutic and diagnostic value.

Authors:  Bo Xu; Tieyi Yang; Zhi Wang; Yan Zhang; Shuyi Liu; Mingquan Shen
Journal:  Cancer Manag Res       Date:  2018-10-23       Impact factor: 3.989

Review 3.  LncRNA H19: A novel oncogene in multiple cancers.

Authors:  Jun Yang; Manlong Qi; Xiang Fei; Xia Wang; Kefeng Wang
Journal:  Int J Biol Sci       Date:  2021-07-25       Impact factor: 6.580

4.  Pharmacodynamics and pharmacokinetics of PLGA-based doxorubicin-loaded implants for tumor therapy.

Authors:  Peng He; Shenglin Xu; Zehao Guo; Peng Yuan; Yulei Liu; Yu Chen; Tiantian Zhang; Yukang Que; Yong Hu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

Review 5.  CircRNA ciRS-7: a Novel Oncogene in Multiple Cancers.

Authors:  Junwen Chen; Jun Yang; Xiang Fei; Xia Wang; Kefeng Wang
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.